−/− mice represent an animal model for the infantile form of sialic acid storage disease (SASD). We analyzed genetic and histological time-course expression of myelin and oligodendrocyte (OL) lineage markers in different parts of the CNS, and related this to postnatal neurobehavioral development in these mice. Sialin-deficient mice display a distinct spatiotemporal pattern of sialic acid storage, CNS hypomyelination and leukoencephalopathy. Whereas few genes are differentially expressed in the perinatal stage (p0), microarray analysis revealed increased differential gene expression in later postnatal stages (p10-p18). This included progressive upregulation of neuroinflammatory genes, as well as continuous down-regulation of genes that encode myelin constituents and typical OL lineage markers. Age-related histopathological analysis indicates that initial myelination occurs normally in hindbrain regions, but progression to more frontal areas is affected in Slc17a5 −/− mice. This course of progressive leukoencephalopathy and CNS hypomyelination delays neurobehavioral development in sialin-deficient mice. Slc17a5 −/− mice successfully achieve early neurobehavioral milestones, but exhibit progressive delay of later-stage sensory and motor milestones. The present findings may contribute to further understanding of the processes of CNS myelination as well as help to develop therapeutic strategies for SASD and other myelination disorders.
Introduction
Sialic acid storage disease (SASD) is an autosomal recessive lysosomal storage disorder caused by deficiency of the lysosomal membrane transporter sialin, and ensuing intralysosomal accumulation of free sialic acid and other acidic monosaccharides. Sialin is encoded by the SLC17A5 gene, mutations of which give rise to SASD (Mancini et al., 1989; Mancini et al., 1991; Havelaar et al., 1998; Verheijen et al., 1999) . Salla disease (OMIM #604369) and infantile sialic acid storage disease (ISSD; OMIM #269920) represent 2 major clinical phenotypes of SASD at either end of the disease spectrum. Children suffering from ISSD present with severe neurodevelopmental defects that rapidly deteriorate, leading to early death. Salla disease does involve psychomotor and cognitive disability, but patients experience a slower deterioration than ISSD patients and survive into adulthood (Haataja et al., 1994) .
Myelination defects occur in clinical SASD as well as in mice with sialin deficiency (Prolo et al., 2009 ), but little is known about their progression and pathological concomitants. SASD leads to progressive cerebellar atrophy as well as decreased cerebral white matter volume, which have been suggested to be caused by hypomyelination (i.e., insufficient myelin deposition and/or maturation), rather than myelin breakdown (Haataja et al., 1994; Sonninen et al., 1999; Varho et al., 2000; Parazzini et al., 2003; Morse et al., 2005; Steenweg et al., 2010) . The process of myelination comprises a sequence of intricate developmental events that start by oligodendrocyte progenitors (OPs) proliferating in the ventral part of the embryonic neural tube (Baumann and Pham-Dinh, 2001; Miller, 2002; Miller, 2005; Kessaris et al., 2006; Bercury and Macklin, 2015) . These OPs subsequently migrate dorsally and rostrally throughout the forebrain and spinal cord, contact axons, and differentiate into myelin-forming oligodendrocytes (OLs). The OL lineage is generally divided into four stages: early OPs, preoligodendrocytes or late OPs, immature OL and mature OL. Craig et al. (2003) studied the analogy of human and rodent OL lineage progression. Their quantification of these events in rodents revealed that cerebral white matter mainly contains late OPs at postnatal day 2 (p2), whereas immature OLs remain a minority (Craig et al., 2003) . Later (around p7), immature OLs become the majority and initiate myelination.
Sialin-deficient mice were generated to study the pathophysiological mechanisms of clinical SASD (Prolo et al., 2009; Moechars et al., 2005) . Sialin deficiency was indeed shown to cause hypomyelination in these mice, which was attributed to defective OL lineage maturation, leading to cell death and functional defects. Clinical SASD studies showed that functional capacities of patients were related to their levels of residual sialin activity (Wreden et al., 2005; Ruivo et al., 2008) . In the present report, we further detailed the various histopathological features of postnatal progressive leukoencephalopathy in sialin-deficient mice, and assessed their functional consequences. Genetic and histological time-course expression of myelin, OL lineage and other pathogenically relevant markers was examined during postnatal brain development. Finally, we identified milestones of neurobehavioral development in mouse pups to document potential developmental disabilities caused by their sialin deficiency. Our results provide new insights on the pathophysiological mechanisms of SASD hypomyelination and could contribute to therapeutic strategies in these and more common myelination disorders.
Results

Slc17a5
−/− mice show a progressive disease course and premature mortality
The Slc17a5 −/− mice were first presented in 2005 (Moechars et al., 2005) and have been previously characterized (Prolo et al., 2009 Next, we confirmed that these elevated levels could indeed be linked to defective sialin-mediated lysosomal clearance. Proton-gradient mediated transport, featuring tritiated glucuronic acid as a sialin substrate, was assessed using purified lysosomal membrane vesicles from livers of rat (RLV), Slc17a5 +/+ , Slc17a5 +/− and Slc17a5 −/− mice. Increased mouse (KO). For comparison free sialic acid was also measured in human skin fibroblasts from controls (CON) and the three clinical variants of SASD, infantile (ISSD), intermediate (INT) and Salla (SAL) type. (B) Transport activity of sialin in purified lysosomal membrane vesicles of mouse livers. Uptake of radiolabeled glucuronic acid in WT, HET and KO mice was evaluated. Activity was measured in the presence (+) and in the absence (−) of a proton gradient. As reference, activity was also measured in rat liver vesicles (RLV). Data are presented as mean + SEM.
uptake of glucuronic acid was observed in rat as well as Slc17a5 +/+ and Slc17a5 +/− mouse vesicles upon acidification of the environment (+) (Mancini et al., 1989) . However, lysosomal vesicles prepared from Slc17a5 −/− mice showed completed absence of increased substrate-uptake (− versus +), confirming defective lysosomal transport through sialin (Fig. 1B) . throughout the entire nervous system was cytoplasmic vacuolization (Fig. 2) . Vacuolization was observed in neuronal and non-neuronal CNS cells of Slc17a5 −/− mice, such as hippocampal neurons (Fig. 2B ), ependymal cells ( Fig. 2D) , cerebellar Purkinje cells (Fig. 2F) , spinal cord neurons (not shown) and astroglial cells (Fig. 2J ). This was in contrast to respective CNS cells of Slc17a5 +/+ mice ( Fig. 2A,C of upregulated genes pointed to a progressive neuroinflammatory response with a notable increased presence of activated phagocytic macrophages (Mpeg1). SAM analysis also identified other genes involved in cholesterol and lipid biosynthesis to be differentially expressed in the brain of Slc17a5 −/− mice, mainly at reduced levels. Expression of many known genes encoding constituents of myelin, the compact lamellar wrapping found on relative large fiber axons, was decreased. Examples of these are MBP, myelin-associated oligodendrocytic basic protein (Mopb), myelin-associated glycoprotein (Mag), cyclic nucleotide phosphodiesterase 1 (Cnp1), proteolipid protein 1 (Plp1), and oligodendrocyte-myelin glycoprotein (Omg). Genes that encode typical markers of OL lineage, the neural tube derived cells that form myelin, were also found to be expressed at reduced levels in the brain of Slc17a5 −/− mice. Expression of Myrf, a transcription factor which directly regulates differentiation of OLs and their expression of myelin genes was downregulated at p18. Apart from these markers, a wide variety of genes expressed predominantly or exclusively in the OLs or reported to be involved in myelin formation or OL function were also found to be expressed at reduced levels in the brain of Slc17a5
mice. The observed decreased expression of such a wide variety of OL and myelin marker genes points to a strong reduction in the number of mature OLs in the brain of the sialin-deficient mouse.
−/− mice show a distinct spatiotemporal pattern of CNS hypomyelination In relation to the progressive downregulation of OL and myelin marker genes during postnatal brain development, we investigated age-and region-specific CNS myelination patterns in Slc17a5 −/− mice.
In contrast to PNS observations, myelination of CNS nerve fibers proved obviously decreased in Slc17a5 −/− mice. In Slc17a5 +/+ brains from p18 mice, immunofluorescence of the myelin constituent MBP labeled all nerve tracts as is illustrated in Fig. 6 (A1, B1, C1). In Slc17a5 −/− mice, MBP staining was markedly decreased or even absent in nerve fiber tracts in all investigated brain regions. The decreased and altered MBP immunoreactivity in the CNS of Slc17a5 −/− mice showed a prominent difference between frontal brain regions and (ventral) hind brain/cerebellum (Fig. 6A2, B2 , C2). The most affected cerebral regions include corpus callosum (Fig. 6A2a-B2a ) as well as cingulum, internal and external capsule and most large white matter fiber tracts in the CNS. MBP immunoreactivity was nearly absent in cerebral cortex ( Fig. 6A2b-B2b ).
The remaining MBP-labeling, especially present in dorsal parts of capsula, striatum and larger nerve fibers was variable and had an aberrant clumpy and disorganized pattern in mice and these showed strong neurofilament immunoreactivity. Double labeling immunofluorescence staining of neurofilament and MBP showed clear engulfment of these axonal swellings by fragmented MBP (Fig. 8 middle panel) .
To gain further insight in temporal patterns of CNS myelination, we investigated markers of OL lineage cells in Slc17a5 −/− mice brain during the myelination period (Fig. 9A) . We used three different markers of OL lineage maturation and followed the myelination process through days p2, p7 and p11 in Slc17a5 +/+ and Slc17a5 −/− mice. While O1 and O4 markers both stain immature OL, O4 is also a marker for late OPs (Craig et al., 2003) . MBP was used as a marker for myelinating, mature OL. Shortly after birth, the staining of OPs did not seem to be strikingly different between Slc17a5 +/+ and Slc17a5 −/− mice, as shown by O4 staining at p2, and was mostly visible in ventral reticular brainstem regions. In Slc17a5 +/+ mice, the MBP, O4 and O1 staining progressively diffused through p7 and p11 from the central white matter areas to cerebral cortical areas, capsula interna and externa and corpus callosum. However, while the pool of OPs as well as maturing OLs weakly increased in brain of Slc17a5 −/− mice, as seen by staining at p7 and p11
for the different OL lineage markers, it remained localized in central brainstem areas and was weakly present in cerebellar white matter (Fig. 9B ).
−/− mice show progressive delay of neurobehavioral development Finally, we assessed neurobehavioral development of Slc17a5 −/− mice to characterize the functional consequences of the observed genetic and pathological alterations. Achievement of developmental milestones ( Fig. 10) and performance level for some of these behaviors (Fig. 11) was assessed from p1 to p21. Early milestone behaviors include negative geotaxis (turning the body head up when placed head down on an incline), cliff aversion (crawling away when placed at an edge) and surface righting (righting the body when placed on the back). These behaviors reflect a postural reflex in response to altered body orientation as well as physical strength and coordinated movement. Slc17a5 −/− mice showed similar performance to control littermates in negative geotaxis and cliff aversion ( Fig. 10 ; Fig. 11A-B) . Milestone criterion for surface righting was also reached at the same time (Fig. 10) , although performance speed was lower, especially during the first perinatal and neonatal days ( Fig. 11C ; main effect of genotype; p b 0.01). All later-stage motor and sensory milestones were significantly retarded in these mice (Fig. 10) . Tactile 
Discussion
Sialin-deficient mice were generated to study the pathophysiology of clinical SASD (Prolo et al., 2009; Moechars et al., 2005) . Sialin deficiency induced free sialic acid accumulation in these mice, and mimicked SASD-related leukoencephalopathy and clinical ISSD. Protongradient mediated transport of glucuronic acid was deficient in lysosomal vesicles from Slc17a5 −/− mice, confirming defective sialin-mediated transport. Free sialic acid accumulated in cultured Slc17a5 −/− mouse fibroblasts, and vacuolization with strong lysosomal marker LAMP-1 immunoreactivity occurred in all examined tissues (including CNS and PNS). These observations confirm that Slc17a5 −/− mice reproduce the basic pathogenic events of the human disorder. In the present report, we examined the occurrence of pathognomonic genetic, histopathological and behavioral anomalies in this putative ISSD model. An overview of the overall set of findings can be found in Fig. 12 .
Hypomyelination is a typical pathological and neuroradiological finding in brain of SASD patients (Haataja et al., 1994; Sonninen et al., 1999; Varho et al., 2000; Parazzini et al., 2003; Morse et al., 2005; Steenweg et al., 2010) . Even in mildly affected Salla disease patients, cerebral hypomyelination seems to be the most consistent abnormality, observed already at the age of 3 to 6 months, well before the first neurological symptoms occur (Sonninen et al., 1999; Biancheri et al., 2002) . Severe hypomyelination in cerebral and cerebellar white matter has been reported from birth in ISSD patients, consistent with prenatally arrested myelination (Parazzini et al., 2003 ). Hypomyelination appears to be a consequence of insufficient myelin deposition in sialin-deficient mice as well. Brains of Slc17a5 −/− mice were examined histologically at an age at which the myelination process is still ongoing (p18). Strongly reduced myelin staining indicated defective myelination, which appears related to a reduction of mature and possibly immature OLs. Microarray analyses further indicated that, already at p10 and markedly at p18, expression of a wide variety of OL and myelin marker genes was reduced in Slc17a5 −/− mice, consistent with a strong reduction of mature OL. For example, Myrf expression was unchanged at p0 but downregulated at p10 and p18 in Slc17a5 −/− mice. Notably, the transcription factor Myrf is crucial for OL maturation and subsequent myelination processes (Emery et al., 2009) . It was shown to be decreased in the mouse model for Niemann-Pick Type C1 disease (Yan et al., 2011) , another lysosomal storage disorder characterized by perturbed myelination. In perinatal mice, Myrf expression by myelinating OLs is limited to the spinal cord and posterior brain regions (Emery et al., 2009 ). This supports initial normal myelination in caudal CNS regions of Slc17a5
Histological analysis at p18 indeed showed a gradient of OL density with highest numbers in ventral hindbrain, followed by midbrain, and forebrain SVZ, further decreasing in more distant areas. Oligodendrogenesis is a late-stage process in brain development (El Waly et al., 2014) . Directed OP migration and differentiation are still ongoing in the first postnatal weeks and are essential for myelin formation. Immunohistochemistry indicated impaired colonization by immature OPs (O1 + and O4 +) and consequently mature OL (MBP +) during later neonatal stages, whereas no obvious differences were observed in central brainstem areas shortly after birth (p2). The reduced O4 distribution from posterior to rostral brain regions may suggest a contribution of defective late OP migration to the observed hypomyelination. Expression of early OL precursor markers such as Pdgfra and Cspg4 did however not change during postnatal brain development, in line with previous immunohistochemical findings ( Prolo et al., 2009) . Early OPs represent the major migratory stage of the OL lineage and transition to late OPs is accompanied by a substantial reduction in migratory capacity (Warrington et al., 1993; Barateiro and Fernandes, 2014) . Notably, performance of a neurosphere in vitro assay on neural stem cells of sialin-deficient mice could be an interesting suggestion for future research. This could further elucidate the involvement of sialin in the different steps of the generation of myelinating oligodendrocytes. Likewise, microarray analyses at p0 could provide more information on the early stages of pathogenesis. In contrast to the pronounced reduction in expression of myelin and OL marker genes at late developmental stages, few genes were differentially expressed at p0. Microarray analysis showed early upregulation and progressive differential expression of lysosomal genes, indicating changes in lysosomal structure and function, probably in response to accumulating storage. Increases in lysosomal size and number, and consequently also lysosomal proteins are common observations in lysosomal storage disorders (Malone, 1976) . In addition, a small subset of inflammatory genes was already upregulated at this stage, suggesting an inflammatory response that preceded reduced myelination. Substantially more inflammatory genes became upregulated later in development, evident of progressive neuroinflammation in sialin-deficient mice. Progressive neuroinflammation is frequently observed in lysosomal storage disorders and could amplify hypomyelination by eliciting apoptosis (Fletcher et al., 1812) . Increased cell death and impaired downregulation of polysialylated neural cell-adhesion molecule (PSA-NCAM) were observed in optic nerves of Slc17a5 −/− mice, and postulated to underlie impaired myelination (Prolo et al., 2009) . Developing oligodendrocytes and late OPs in particular were shown to be increasingly vulnerable to inflammatory and other insults (Back et al., 2002; Deng, 2010; Falahati et al., 2013) , suggesting a substantial contribution of neuroinflammation to the apparent defect of Slc17a5 −/− mice in transition of early to late OPs and more mature cells in the OL lineage. In addition, we investigated the degree to which CNS hypomyelination and leukoencephalopathy in Slc17a5 −/− mice affected their neurobehavioral performance. Slc17a5 −/− mice seem to model clinical ISSD, which is characterized by severe functional impairments and developmental delays (Lemyre et al., 1999) . At a rather late stage of their disease, sialin-deficient mice displayed reduced ambulation in the open field test, which might at least partly relate to the gait abnormalities described in these mice (Prolo et al., 2009 ). We did not observe any gross abnormalities in cerebellar development, but focal axonal swellings were observed at p18 throughout the cerebellum, which are indicative for impaired axonal transport and fiber degeneration (Prolo et al., 2009; Lovell and Jones, 1985; Kaartinen et al., 1996; Suzuki, 2003) and considered an important factor in generating movement disorders in lysosomal storage diseases (Walkley et al., 2010) . Slc17a5 −/− mice showed a progressive delay of milestone achievement that paralleled the course of their leukoencephalopathy. They showed timely achievement of early milestones (cliff aversion, negative geotaxis and surface righting), whereas surface righting performance was impaired. The righting reflex, which depends on vestibular system and brainstem integrity, appears intact in Slc17a5 −/− mice, but its execution could be more difficult depending on the postural adjustment required. Notably, myelination (especially in brainstem) was not severely affected during the early perinatal days, but declined later on. Additionally, these mice displayed severe delays in reaching the developmental milestone of air righting, also reliant on labyrinthine function, but requiring further maturation of the motor coordination system (Altman and Sudarshan, 1975) . In addition, Slc17a5 −/− mice showed delayed forelimb grasping as well as retarded transition from pivoting to crawling, indicating delayed maturation of hindlimb use. Moreover, they never reached the same level of straightforward locomotion as littermate controls, typical of later developmental stages. By and large, the aberrant neuromotor development in Slc17a5 −/− mice seems to parallel the spatiotemporal progression of their leukoencephalopathy, supporting a causal role of defective myelinogenesis and central hypomyelination in SASD-induced motor defects. Delayed development of motor skills and/or ataxia are also typical in other human genetic hypomyelination disorders such as Pelizaeus-Merzbacher disease (Regis et al., 2008) and vanishing white matter disease (van der Lei et al., 2010) , as well as in animal models of central hypomyelination such as shiverer mutant mice (Low et al., 2009) . Notably, some functional impairments of sialin-deficient mice, such as their delayed tactile ear twitch reflex, could also be attributed to somatosensory defects. Also at the sensory level, Slc17a5 −/− mice developed no auditory startle responses during the measured timeframe. Auditory impairment indeed appears to be another characteristic consequence of central myelination defects. For example, delayed auditory evoked potentials were observed in a mouse model of Canavan disease as well (Carpinelli et al., 2014; von Jonquieres et al., 2014) . The present report links sialin deficiency to impaired OL lineage development, and demonstrated that the resulting leukoencephalopathy causes a distinct pattern of neurodevelopmental dysfunctions. In general, sialin deficiency clearly impairs the complex mechanisms of brain myelination. Steps involved in the generation of oligodendrocytes and myelin correlate to events of remyelination after myelin damage. Studies in sialin knock-out mice could therefore also contribute to pathophysiological and therapeutic research about more common myelination disorders.
Materials & methods
Slc17a5 knockout mice
Slc17a5 knockout mice were developed in collaboration with Lexicon Genetics Inc. and presented in 2005 (Moechars et al., 2005) . Animals were maintained in an SPF facility that meets all Belgian and European requirements for animal care. Mice were group-housed in a climate-controlled animal colony with a 12 h dark-light cycle (light on 7:00 EST) with free access to food and water, except during behavioral testing. Adequate measures were taken to minimize pain or discomfort. All experiments were carried out in accordance with the European Communities Council Directives (86/609/EEC) and were approved by the local ethical committee. 
Fibroblast isolation and free sialic acid measurement
Primary mouse embryonic fibroblast (MEF) cultures were established by standard procedures from individual embryonic day 13.5 (E13.5) embryos derived from heterozygous matings of Slc17a5 +/− mice. Permanent Slc17a5
cell lines were established from transformed clones arising spontaneously after repeated passage in culture (Todaro et al., 1963) . MEFs were cultured in DMEM high glucose with L-glutamine, 10% FBS and penicillin/streptomycin. When confluent, cells were cryopreserved before sialic acid determination according to a modified thiobarbituric acid test (Mancini et al., 1991 
Biochemistry
In order to evaluate a defect of sialin function in Slc17a5 −/− mice, the proton driven uptake of a sialin-substrate was evaluated using rat liver lysosomal vesicles (RLV) as a reference. Mouse livers were freshly dissected from 18 days old mice, either six Slc17a5
, or six Slc17a5 +/+ mice, after overnight fasting. About 1.5 to 3 g wet weight livers were obtained from each mouse group. Lysosomal membrane vesicles were prepared using a differential centrifugation method as described (Mancini et al., 1989) . Functional transport assays with lysosomal membrane vesicles were performed as described for rat livers with some adaptations as described for human lysosomal membrane vesicles, using tritiated glucuronic acid as a substrate (Mancini et al., 1991) .
Micro-array analysis
Total brain RNA was isolated from newborn (p0) as well as 10 (p10) and 18 days (p18) old pups derived from heterozygous breeding pairs using the RNeasy kit (Qiagen, Venlo, Netherlands) combined with DNAse treatment. One microgram of extracted total RNA was biotin labeled and hybridized with the Mouse Genome 430 version 2.0 GeneChip array (Affymetrix, Orbassano, Italy). All data were processed by using the statistical computing R-program (R version 2.4.0) (R Development Core Team, URL www.R-project.org, 2006) and Bioconductor Fig. 11 . Decreased performance of milestone behaviors in sialin-deficient mice. Slc17a5−/− mice (KO, white dots) show similar performance for milestone behaviors of cliff aversion and negative geotaxis in comparison to control littermates (CON, black dots). These mice showed reduced performance for surface righting however (main effect of genotype p b 0.05). They also showed increased exit latencies in the locomotion test, which were less pronounced during p8-9 and p16 (main effect of genotype p b 0.001, day × genotype interaction p b 0.05). Data are presented as mean + SEM. tools (Gentleman et al., 2004) . Gene expressions were computed using the FARMS algorithm (Hochreiter et al., 2006) . Grouping of the individual probes into gene-specific probe sets was performed based on the Entrez Gene using the metadata package mm430mmentrezg (version 8). All analysis of the microarray data were done at three levels: spectral map analysis (Wouters et al., 2003) , significance analysis of microarray (SAM, at FDR b 0.005) (Tusher et al., 2001 ) and analysis of affected processes.
Tissue processing for histology
Five Homozygous Slc17a5
−/− and five Slc17a5 +/+ mice were sacrificed by cervical dislocation and decapitation at p18. Brain tissue and spinal cord were embedded in paraffin or cryopreservation in OCT by freezing at − 40°C. To study the OL lineage, brain tissue of Slc17a5 −/− and Slc17a5 +/+ mice at p2, p7 and p11 was processed in the same way. Paraffin embedded material was sectioned at 6 μm whereas cryopreserved samples were sectioned at 10 μm. Ischiadic nerves were processed by plastic embedding.
Histology
Routine morphological evaluation of all tissue sections was performed on hematoxylin phloxin saffrane (HPS) stained sections and Nissl stained sections for brain specific questions. Toluidine Blue staining was used to investigate peripheral nerve morphology.
Immunohistochemistry
LAMP-1 (lysosomal associated membrane protein, isoform 1) (Abcam, Cambridge, UK) (1/500) and GFAP (Dako Cytomation, 1/100) staining was performed after heat-induced epitope retrieval and visualized by Envision + System-HRP Labeled Polymer (Dako, Denmark), followed by DAB.
Immunofluorescence techniques
All immunofluorescence stains on deparaffinised sections required an enzymatic pre-treatment of trypsin followed by heat mediated microwave antigen retrieval using EDTA. Immunohistochemistry on 10 μm thick cryosections required 4% paraformaldehyde fixation prior to incubation with the primary antibodies. Prior to incubation with mouse monoclonal antibodies, blocking stages were performed using 10% normal goat serum (Dako, Denmark) with subsequent endogenous mouse IgG blocking (Goat-anti-Mouse F'ab fragments, Jackson Immunoresearch Laboratories, Inc., PA, USA). Mouse monoclonal antibodies used are: anti-MBP (SMI-94, Abcam Ltd., Cambridge, UK) (1/ 1000), anti-O1 and -O4 (Chemicon Int., CA USA) (1/100) and anti-neurofilament proteins of 70-and 200-kDa (Euro-Diagnostica bv, Netherlands) (1/100). These monoclonal antibodies were visualized using Cy3 conjugated goat anti-mouse IgG (Jackson Immunoresearch Laboratories, Inc., PA, USA) (1/500), Alexa555 conjugated goat anti-mouse IgM (Invitrogen Corporate, Molecular Probes, California, USA) (1/500) or Alexa488 conjugated goat anti-mouse IgG (Invitrogen Corporate, Molecular Probes, California, USA) (1/100) depending on the application. Rabbit polyclonal antibodies used are anti-GFAP (Dako Cytomation) (1/100) and anti-MBP (Abcam Ltd., Cambridge, UK) (1/100). These are visualized by Cy3 conjugated goat anti-rabbit IgG (Jackson Immunoresearch Laboratories, Inc., PA, USA) (1/500) or Alexa488 conjugated goat anti-rabbit IgG (Invitrogen Corporate, Molecular Probes, California, USA) (1/100) depending on the application. All sections were counterstained with Hoechst (Invitrogen Corporate, Molecular Probes, California, USA) (1/500).
Imaging and analysis
Imaging was performed on Axioplan-2 Imaging microscope (Carl Zeiss, Germany) equipped with a high resolution Axiocam camera and the Multidimensional and Mosaics modules of the imaging software Axiovision Release 4.6. Quantitative analysis of the number of cortical neuronal and non-neuronal cells and of cerebellar Purkinje cells was performed in 10 fields at a 63× magnification in transversal sections of 5 Slc17a5 −/− and Slc17a5 +/+ mouse brains at P18. The 10 regions analyzed were randomly chosen throughout the entire cortex and Purkinje cell layer. One region corresponds to 0.096 mm 2 using a 63× objective and eyepiece with field number 22. Results were analyzed by a nonparametrical Wilcoxon Krüskal-Wallis test.
Neurobehavioral development
Developmental milestones were daily evaluated in neonatal mice of all genotypes (p1-p21). No obvious differences were observed between heterozygous and wildtype mice, hence they were compared as one control group (n = 38) to performance of sialin knockout mice (n = 11). The developmental test battery (adapted from (Hill et al., 2008) ) involved assessment of milestone achievement and speed of execution of milestone behaviors. Specifically, the following behaviors were examined during the relevant period of age: surface righting (time for a pup to turn over after being held on its back; max 30 s -milestone criterion 1 s); negative geotaxis (time for a pup to turn after being placed head-down on a 45°slope; max 30 s -milestone criterion b 10 s); cliff aversion (time for a pup, placed at the edge of a plastic box, to turn away from the edge; max 30 s -milestone criterion b10 s); forelimb grasping (ability of a pup to grip a thin bar with its forepaws; milestone criterion 1 s); locomotion development (time for a pup to exit a 13-cm diameter circle; max 30 s -milestone criterion b10 s); air righting (ability of a pup, after being held upside down and released at~11 cm height, to turn and land on all paws). Sensory developmental markers were also evaluated: auditory startle (appearance of a startle response to a handclap at~10 cm); ear twitch (appearance of ear twitching after tactile stimulation with a cotton swab tip). If the milestone behavior was not exhibited during the observed time period, milestone achievement was quantified as 'last day of testing + 1'. Data were analyzed using ttests (for milestone achievement data) and repeated-measures ANOVA (for performance data).
Open field test
A panel of eight Slc17a5
+/+ , eight Slc17a5 +/− and five Slc17a5 −/− , aged between six and seven weeks were subjected to the OFT, which was performed during the light phase of a normal light/dark cycle. A large arena (40 cm × 40 cm) with infrared beams at three different levels was used to record rearing and locomotor activity. The animal was placed in the center and its activity was measured for 20 min. Data from this test were analyzed in five, 4-minute intervals. The total distance traveled (cm) and vertical movement number (rearing) were recorded. Data were analyzed using a t-test.
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